0.1900
27-November-24 15:45:00
15 minutes delayed
Stocks
-0.0083
-4.19%
Today's range
0.1839 - 0.2070
ISIN
N/A
Source
NASDAQ
Lyra Therapeutics Announces Positive Topline Results of Pharmacokinetic Study of LYR-210 in Patients with Chronic Rhinosinusitis
30 Jun 2021 06:00:00 By Nasdaq GlobeNewswire